
### [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161)
**Label:** Leukemia

**Subclasses:** [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C5440](http://purl.obolibrary.org/obo/NCIT_C5440) (Central Nervous System Leukemia), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C122603](http://purl.obolibrary.org/obo/NCIT_C122603) (Infant Leukemia), [NCIT:C122725](http://purl.obolibrary.org/obo/NCIT_C122725) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q), [NCIT:C122726](http://purl.obolibrary.org/obo/NCIT_C122726) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7), [NCIT:C134835](http://purl.obolibrary.org/obo/NCIT_C134835) (Refractory Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C134834](http://purl.obolibrary.org/obo/NCIT_C134834) (Recurrent Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C7876](http://purl.obolibrary.org/obo/NCIT_C7876) (Stage III Chronic Lymphocytic Leukemia), [NCIT:C7875](http://purl.obolibrary.org/obo/NCIT_C7875) (Stage II Chronic Lymphocytic Leukemia), [NCIT:C9019](http://purl.obolibrary.org/obo/NCIT_C9019) (Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C122617](http://purl.obolibrary.org/obo/NCIT_C122617) (Infant Acute Lymphoblastic Leukemia with MLL Rearrangement), [NCIT:C9018](http://purl.obolibrary.org/obo/NCIT_C9018) (Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C7874](http://purl.obolibrary.org/obo/NCIT_C7874) (Stage I Chronic Lymphocytic Leukemia), [NCIT:C122614](http://purl.obolibrary.org/obo/NCIT_C122614) (Infant Acute Lymphoblastic Leukemia), [NCIT:C9020](http://purl.obolibrary.org/obo/NCIT_C9020) (Acute Myelomonocytic Leukemia with Abnormal Eosinophils), [NCIT:C9142](http://purl.obolibrary.org/obo/NCIT_C9142) (Adult T Acute Lymphoblastic Leukemia), [NCIT:C138192](http://purl.obolibrary.org/obo/NCIT_C138192) (Leukemic Nonnodal Mantle Cell Lymphoma), [NCIT:C9381](http://purl.obolibrary.org/obo/NCIT_C9381) (Childhood Acute Myeloid Leukemia with Maturation), [NCIT:C9140](http://purl.obolibrary.org/obo/NCIT_C9140) (Childhood B Acute Lymphoblastic Leukemia), [NCIT:C37202](http://purl.obolibrary.org/obo/NCIT_C37202) (Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation), [NCIT:C9380](http://purl.obolibrary.org/obo/NCIT_C9380) (Adult Acute Myeloid Leukemia without Maturation), [NCIT:C37205](http://purl.obolibrary.org/obo/NCIT_C37205) (Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene), [NCIT:C7847](http://purl.obolibrary.org/obo/NCIT_C7847) (Stage 0 Chronic Lymphocytic Leukemia), [NCIT:C7968](http://purl.obolibrary.org/obo/NCIT_C7968) (Childhood Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C3366](http://purl.obolibrary.org/obo/NCIT_C3366) (Sezary Syndrome), [NCIT:C7964](http://purl.obolibrary.org/obo/NCIT_C7964) (Adult Acute Basophilic Leukemia), [NCIT:C7600](http://purl.obolibrary.org/obo/NCIT_C7600) (Acute Myeloid Leukemia with Myelodysplasia-Related Changes), [NCIT:C3249](http://purl.obolibrary.org/obo/NCIT_C3249) (Acute Myeloid Leukemia without Maturation), [NCIT:C7965](http://purl.obolibrary.org/obo/NCIT_C7965) (Adult Acute Megakaryoblastic Leukemia), [NCIT:C7962](http://purl.obolibrary.org/obo/NCIT_C7962) (Adult Acute Myelomonocytic Leukemia), [NCIT:C7961](http://purl.obolibrary.org/obo/NCIT_C7961) (Adult Acute Myeloid Leukemia with Maturation), [NCIT:C122624](http://purl.obolibrary.org/obo/NCIT_C122624) (Refractory Childhood Acute Lymphoblastic Leukemia), [NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant), [NCIT:C122625](http://purl.obolibrary.org/obo/NCIT_C122625) (Childhood Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C126309](http://purl.obolibrary.org/obo/NCIT_C126309) (Refractory Adult Acute Lymphoblastic Leukemia), [NCIT:C3483](http://purl.obolibrary.org/obo/NCIT_C3483) (Chronic Leukemia), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), [NCIT:C7171](http://purl.obolibrary.org/obo/NCIT_C7171) (Acute Monoblastic Leukemia), [NCIT:C122621](http://purl.obolibrary.org/obo/NCIT_C122621) (Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement), [NCIT:C4344](http://purl.obolibrary.org/obo/NCIT_C4344) (Acute Panmyelosis with Myelofibrosis), [NCIT:C8029](http://purl.obolibrary.org/obo/NCIT_C8029) (Progressive Hairy Cell Leukemia Initial Treatment), [NCIT:C3250](http://purl.obolibrary.org/obo/NCIT_C3250) (Acute Myeloid Leukemia with Maturation), [NCIT:C7971](http://purl.obolibrary.org/obo/NCIT_C7971) (Childhood Acute Basophilic Leukemia), [NCIT:C7970](http://purl.obolibrary.org/obo/NCIT_C7970) (Childhood Acute Myelomonocytic Leukemia), [NCIT:C7299](http://purl.obolibrary.org/obo/NCIT_C7299) (Splenic Manifestation of B-Cell Prolymphocytic Leukemia), [NCIT:C7972](http://purl.obolibrary.org/obo/NCIT_C7972) (Childhood Acute Megakaryoblastic Leukemia), [NCIT:C4343](http://purl.obolibrary.org/obo/NCIT_C4343) (Aleukemic Lymphoid Leukemia), [NCIT:C7296](http://purl.obolibrary.org/obo/NCIT_C7296) (Splenic Manifestation of Leukemia), [NCIT:C7175](http://purl.obolibrary.org/obo/NCIT_C7175) (Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C8263](http://purl.obolibrary.org/obo/NCIT_C8263) (Adult Acute Monocytic Leukemia), [NCIT:C7177](http://purl.obolibrary.org/obo/NCIT_C7177) (Aleukemic Acute Lymphoblastic Leukemia), [NCIT:C7298](http://purl.obolibrary.org/obo/NCIT_C7298) (Splenic Manifestation of T-Cell Prolymphocytic Leukemia), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7176](http://purl.obolibrary.org/obo/NCIT_C7176) (Aleukemic Chronic Lymphocytic Leukemia), [NCIT:C7297](http://purl.obolibrary.org/obo/NCIT_C7297) (Splenic Manifestation of Prolymphocytic Leukemia), [NCIT:C8030](http://purl.obolibrary.org/obo/NCIT_C8030) (Refractory Hairy Cell Leukemia), [NCIT:C7940](http://purl.obolibrary.org/obo/NCIT_C7940) (Childhood Acute Monoblastic and Monocytic Leukemia), [NCIT:C4673](http://purl.obolibrary.org/obo/NCIT_C4673) (Acute Biphenotypic Leukemia), [NCIT:C8594](http://purl.obolibrary.org/obo/NCIT_C8594) (Leukemic Phase of Lymphoma), [NCIT:C128629](http://purl.obolibrary.org/obo/NCIT_C128629) (B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative), [NCIT:C7953](http://purl.obolibrary.org/obo/NCIT_C7953) (Childhood T Acute Lymphoblastic Leukemia), [NCIT:C7952](http://purl.obolibrary.org/obo/NCIT_C7952) (Childhood Burkitt Leukemia), [NCIT:C136488](http://purl.obolibrary.org/obo/NCIT_C136488) (Refractory Acute Lymphoblastic Leukemia), [NCIT:C8923](http://purl.obolibrary.org/obo/NCIT_C8923) (Acute Erythroid Leukemia), [NCIT:C7954](http://purl.obolibrary.org/obo/NCIT_C7954) (Adult Burkitt Leukemia), [NCIT:C82212](http://purl.obolibrary.org/obo/NCIT_C82212) (Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified), [NCIT:C82213](http://purl.obolibrary.org/obo/NCIT_C82213) (Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified), [NCIT:C4563](http://purl.obolibrary.org/obo/NCIT_C4563) (Chronic Eosinophilic Leukemia, Not Otherwise Specified), [NCIT:C82217](http://purl.obolibrary.org/obo/NCIT_C82217) (Natural Killer Cell Lymphoblastic Leukemia/Lymphoma), [NCIT:C36312](http://purl.obolibrary.org/obo/NCIT_C36312) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C27753](http://purl.obolibrary.org/obo/NCIT_C27753) (Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C45264](http://purl.obolibrary.org/obo/NCIT_C45264) (Cutaneous Chronic Lymphocytic Leukemia), [NCIT:C82203](http://purl.obolibrary.org/obo/NCIT_C82203) (Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C9300](http://purl.obolibrary.org/obo/NCIT_C9300) (Acute Leukemia), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C27757](http://purl.obolibrary.org/obo/NCIT_C27757) (Microgranular Acute Promyelocytic Leukemia), [NCIT:C27756](http://purl.obolibrary.org/obo/NCIT_C27756) (Typical Acute Promyelocytic Leukemia), [NCIT:C8460](http://purl.obolibrary.org/obo/NCIT_C8460) (Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C132101](http://purl.obolibrary.org/obo/NCIT_C132101) (Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10), [NCIT:C5631](http://purl.obolibrary.org/obo/NCIT_C5631) (Aleukemic Acute Lymphoblastic Leukemia Cutis), [NCIT:C4664](http://purl.obolibrary.org/obo/NCIT_C4664) (T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C82433](http://purl.obolibrary.org/obo/NCIT_C82433) (Acute Myeloid Leukemia with Mutated CEBPA), [NCIT:C5630](http://purl.obolibrary.org/obo/NCIT_C5630) (Aleukemic Monocytic Leukemia Cutis), [NCIT:C68700](http://purl.obolibrary.org/obo/NCIT_C68700) (Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C82430](http://purl.obolibrary.org/obo/NCIT_C82430) (Acute Myeloid Leukemia with Gene Mutations), [NCIT:C82431](http://purl.obolibrary.org/obo/NCIT_C82431) (Acute Myeloid Leukemia with Mutated NPM1), [NCIT:C126111](http://purl.obolibrary.org/obo/NCIT_C126111) (Infant Acute Biphenotypic Leukemia), [NCIT:C126110](http://purl.obolibrary.org/obo/NCIT_C126110) (Infant Acute Undifferentiated Leukemia), [NCIT:C126112](http://purl.obolibrary.org/obo/NCIT_C126112) (Infant T Acute Lymphoblastic Leukemia), [NCIT:C114819](http://purl.obolibrary.org/obo/NCIT_C114819) (Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C126351](http://purl.obolibrary.org/obo/NCIT_C126351) (Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA), [NCIT:C4752](http://purl.obolibrary.org/obo/NCIT_C4752) (T-Cell Prolymphocytic Leukemia), [NCIT:C4753](http://purl.obolibrary.org/obo/NCIT_C4753) (B-Cell Prolymphocytic Leukemia), [NCIT:C7464](http://purl.obolibrary.org/obo/NCIT_C7464) (Acute Leukemia of Ambiguous Lineage), [NCIT:C82423](http://purl.obolibrary.org/obo/NCIT_C82423) (Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214), [NCIT:C125715](http://purl.obolibrary.org/obo/NCIT_C125715) (Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes), [NCIT:C82426](http://purl.obolibrary.org/obo/NCIT_C82426) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C7463](http://purl.obolibrary.org/obo/NCIT_C7463) (Acute Myelomonocytic Leukemia), [NCIT:C82427](http://purl.obolibrary.org/obo/NCIT_C82427) (Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1), [NCIT:C122687](http://purl.obolibrary.org/obo/NCIT_C122687) (Cytogenetically Normal Acute Myeloid Leukemia), [NCIT:C122688](http://purl.obolibrary.org/obo/NCIT_C122688) (Core Binding Factor Acute Myeloid Leukemia), [NCIT:C134319](http://purl.obolibrary.org/obo/NCIT_C134319) (Refractory Acute Myeloid Leukemia), [NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta), [NCIT:C38377](http://purl.obolibrary.org/obo/NCIT_C38377) (Acute Myeloid Leukemia with t(17;17)(q21;q21)), [NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant), [NCIT:C122690](http://purl.obolibrary.org/obo/NCIT_C122690) (Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6), [NCIT:C80347](http://purl.obolibrary.org/obo/NCIT_C80347) (B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)), [NCIT:C80346](http://purl.obolibrary.org/obo/NCIT_C80346) (B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH), [NCIT:C80345](http://purl.obolibrary.org/obo/NCIT_C80345) (Hypodiploid B Acute Lymphoblastic Leukemia), [NCIT:C80344](http://purl.obolibrary.org/obo/NCIT_C80344) (Hyperdiploid B Acute Lymphoblastic Leukemia), [NCIT:C80343](http://purl.obolibrary.org/obo/NCIT_C80343) (B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1), [NCIT:C80342](http://purl.obolibrary.org/obo/NCIT_C80342) (B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged), [NCIT:C9068](http://purl.obolibrary.org/obo/NCIT_C9068) (Recurrent Childhood Acute Myeloid Leukemia), [NCIT:C82403](http://purl.obolibrary.org/obo/NCIT_C82403) (Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C68698](http://purl.obolibrary.org/obo/NCIT_C68698) (Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C68699](http://purl.obolibrary.org/obo/NCIT_C68699) (Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C68696](http://purl.obolibrary.org/obo/NCIT_C68696) (Adult Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C68697](http://purl.obolibrary.org/obo/NCIT_C68697) (Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C6923](http://purl.obolibrary.org/obo/NCIT_C6923) (Acute Bilineal Leukemia), [NCIT:C4989](http://purl.obolibrary.org/obo/NCIT_C4989) (Childhood Leukemia), [NCIT:C6924](http://purl.obolibrary.org/obo/NCIT_C6924) (Acute Myeloid Leukemia with Variant MLL Translocations), [NCIT:C4982](http://purl.obolibrary.org/obo/NCIT_C4982) (Aleukemic Leukemia), [NCIT:C4861](http://purl.obolibrary.org/obo/NCIT_C4861) (Acute Monocytic Leukemia), [NCIT:C4983](http://purl.obolibrary.org/obo/NCIT_C4983) (Aleukemic Leukemia Cutis), [NCIT:C8304](http://purl.obolibrary.org/obo/NCIT_C8304) (Childhood Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C8303](http://purl.obolibrary.org/obo/NCIT_C8303) (Adult Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C42779](http://purl.obolibrary.org/obo/NCIT_C42779) (Acute Myelomonocytic Leukemia without Abnormal Eosinophils), [NCIT:C25765](http://purl.obolibrary.org/obo/NCIT_C25765) (Secondary Acute Myeloid Leukemia), [NCIT:C129786](http://purl.obolibrary.org/obo/NCIT_C129786) (Acute Myeloid Leukemia with Mutated RUNX1), [NCIT:C80691](http://purl.obolibrary.org/obo/NCIT_C80691) (Chemotherapy-Related Leukemia), [NCIT:C129785](http://purl.obolibrary.org/obo/NCIT_C129785) (Acute Myeloid Leukemia with BCR-ABL1), [NCIT:C82192](http://purl.obolibrary.org/obo/NCIT_C82192) (Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome), [NCIT:C80683](http://purl.obolibrary.org/obo/NCIT_C80683) (Therapy-Related Leukemia), [NCIT:C7300](http://purl.obolibrary.org/obo/NCIT_C7300) (Splenic Manifestation of Chronic Lymphocytic Leukemia), [NCIT:C7784](http://purl.obolibrary.org/obo/NCIT_C7784) (Recurrent Childhood Acute Lymphoblastic Leukemia), [NCIT:C3183](http://purl.obolibrary.org/obo/NCIT_C3183) (T Acute Lymphoblastic Leukemia), [NCIT:C3182](http://purl.obolibrary.org/obo/NCIT_C3182) (Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C7302](http://purl.obolibrary.org/obo/NCIT_C7302) (Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C7301](http://purl.obolibrary.org/obo/NCIT_C7301) (Splenic Manifestation of Hairy Cell Leukemia), [NCIT:C3181](http://purl.obolibrary.org/obo/NCIT_C3181) (Prolymphocytic Leukemia), [NCIT:C9288](http://purl.obolibrary.org/obo/NCIT_C9288) (Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C9289](http://purl.obolibrary.org/obo/NCIT_C9289) (Acute Myeloid Leukemia with Multilineage Dysplasia), [NCIT:C9287](http://purl.obolibrary.org/obo/NCIT_C9287) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C7319](http://purl.obolibrary.org/obo/NCIT_C7319) (Adult Acute Monoblastic and Monocytic Leukemia), [NCIT:C7318](http://purl.obolibrary.org/obo/NCIT_C7318) (Acute Monoblastic and Monocytic Leukemia), [NCIT:C4967](http://purl.obolibrary.org/obo/NCIT_C4967) (Adult Acute Lymphoblastic Leukemia), [NCIT:C8647](http://purl.obolibrary.org/obo/NCIT_C8647) (Aggressive NK-Cell Leukemia), [NCIT:C8645](http://purl.obolibrary.org/obo/NCIT_C8645) (Recurrent Chronic Lymphocytic Leukemia), [NCIT:C8646](http://purl.obolibrary.org/obo/NCIT_C8646) (Stage IV Chronic Lymphocytic Leukemia), [NCIT:C82179](http://purl.obolibrary.org/obo/NCIT_C82179) (Mixed Phenotype Acute Leukemia), [NCIT:C8644](http://purl.obolibrary.org/obo/NCIT_C8644) (B Acute Lymphoblastic Leukemia), [NCIT:C9298](http://purl.obolibrary.org/obo/NCIT_C9298) (Acute Undifferentiated Leukemia), [NCIT:C36272](http://purl.obolibrary.org/obo/NCIT_C36272) (Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation), [NCIT:C88156](http://purl.obolibrary.org/obo/NCIT_C88156) (Leukemia Cutis), [NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant), [NCIT:C131875](http://purl.obolibrary.org/obo/NCIT_C131875) (Recurrent Childhood T Acute Lymphoblastic Leukemia), [NCIT:C3169](http://purl.obolibrary.org/obo/NCIT_C3169) (Mast Cell Leukemia), [NCIT:C3168](http://purl.obolibrary.org/obo/NCIT_C3168) (Childhood Acute Lymphoblastic Leukemia), [NCIT:C3167](http://purl.obolibrary.org/obo/NCIT_C3167) (Acute Lymphoblastic Leukemia), [NCIT:C7402](http://purl.obolibrary.org/obo/NCIT_C7402) (Hairy Cell Leukemia), [NCIT:C7886](http://purl.obolibrary.org/obo/NCIT_C7886) (Refractory Chronic Lymphocytic Leukemia), [NCIT:C7883](http://purl.obolibrary.org/obo/NCIT_C7883) (Recurrent Adult Acute Lymphoblastic Leukemia), [NCIT:C121978](http://purl.obolibrary.org/obo/NCIT_C121978) (Acute Lymphoblastic Leukemia by ROSE Cluster), [NCIT:C7882](http://purl.obolibrary.org/obo/NCIT_C7882) (Recurrent Adult Acute Myeloid Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7401](http://purl.obolibrary.org/obo/NCIT_C7401) (Hairy Cell Leukemia Variant), [NCIT:C7400](http://purl.obolibrary.org/obo/NCIT_C7400) (Burkitt Leukemia), [NCIT:C121975](http://purl.obolibrary.org/obo/NCIT_C121975) (DDIT4L Acute Lymphoblastic Leukemia), [NCIT:C3164](http://purl.obolibrary.org/obo/NCIT_C3164) (Acute Basophilic Leukemia), [NCIT:C9143](http://purl.obolibrary.org/obo/NCIT_C9143) (Adult B Acute Lymphoblastic Leukemia), [NCIT:C3163](http://purl.obolibrary.org/obo/NCIT_C3163) (Chronic Lymphocytic Leukemia), [NCIT:C68659](http://purl.obolibrary.org/obo/NCIT_C68659) (Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C9153](http://purl.obolibrary.org/obo/NCIT_C9153) (Adult Acute Erythroid Leukemia), [NCIT:C121974](http://purl.obolibrary.org/obo/NCIT_C121974) (Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C121973](http://purl.obolibrary.org/obo/NCIT_C121973) (Acute Lymphoblastic Leukemia by Gene Expression Profile), [NCIT:C7539](http://purl.obolibrary.org/obo/NCIT_C7539) (Lymphoid Leukemia), [NCIT:C3179](http://purl.obolibrary.org/obo/NCIT_C3179) (Chronic Neutrophilic Leukemia), [NCIT:C122716](http://purl.obolibrary.org/obo/NCIT_C122716) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3172](http://purl.obolibrary.org/obo/NCIT_C3172) (Myeloid Leukemia), [NCIT:C122717](http://purl.obolibrary.org/obo/NCIT_C122717) (Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C3171](http://purl.obolibrary.org/obo/NCIT_C3171) (Acute Myeloid Leukemia), [NCIT:C9158](http://purl.obolibrary.org/obo/NCIT_C9158) (Childhood Acute Myeloid Leukemia without Maturation), [NCIT:C26814](http://purl.obolibrary.org/obo/NCIT_C26814) (Radiation-Related Leukemia), [NCIT:C3170](http://purl.obolibrary.org/obo/NCIT_C3170) (Acute Megakaryoblastic Leukemia), [NCIT:C9277](http://purl.obolibrary.org/obo/NCIT_C9277) (Testicular Leukemia), [NCIT:C9156](http://purl.obolibrary.org/obo/NCIT_C9156) (Adult Acute Monoblastic Leukemia), [NCIT:C3177](http://purl.obolibrary.org/obo/NCIT_C3177) (Philadelphia-Positive Myelogenous Leukemia), [NCIT:C3176](http://purl.obolibrary.org/obo/NCIT_C3176) (Philadelphia-Negative Myelogenous Leukemia), [NCIT:C9154](http://purl.obolibrary.org/obo/NCIT_C9154) (Adult Acute Myeloid Leukemia), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9155](http://purl.obolibrary.org/obo/NCIT_C9155) (Adult Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C9163](http://purl.obolibrary.org/obo/NCIT_C9163) (Childhood Acute Monocytic Leukemia), [NCIT:C9164](http://purl.obolibrary.org/obo/NCIT_C9164) (Childhood Acute Erythroid Leukemia), [NCIT:C9162](http://purl.obolibrary.org/obo/NCIT_C9162) (Childhood Acute Monoblastic Leukemia), [NCIT:C3180](http://purl.obolibrary.org/obo/NCIT_C3180) (Plasma Cell Leukemia), [NCIT:C36058](http://purl.obolibrary.org/obo/NCIT_C36058) (Acute Myeloid Leukemia with t(11;17)(q13;q21)), [NCIT:C9160](http://purl.obolibrary.org/obo/NCIT_C9160) (Childhood Acute Myeloid Leukemia), [NCIT:C36057](http://purl.obolibrary.org/obo/NCIT_C36057) (Acute Myeloid Leukemia with t(5;17)(q35;q21)), [NCIT:C36056](http://purl.obolibrary.org/obo/NCIT_C36056) (Acute Myeloid Leukemia with t(11;17)(q23;q21)), [NCIT:C36055](http://purl.obolibrary.org/obo/NCIT_C36055) (Acute Myeloid Leukemia with a Variant RARA Translocation), 

**Class expressions from DL-Learner:**

- Thing 66.46%
- [NCIT:C36341](http://purl.obolibrary.org/obo/NCIT_C36341) (Signal Transduction Pathway Deregulation) 50.76%
- [NCIT:C39583](http://purl.obolibrary.org/obo/NCIT_C39583) (FAS Apoptosis Pathway Deregulation) 50.19%
- [NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation) 50.19%
- [NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation) 50.19%
- [NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation) 50.19%
- [NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation) 50.19%
- [NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation) 50.19%
- Error9 50.19%
- Error7 50.19%
- Error3 50.19%
- Error20 50.19%
- Error18 50.19%
- Error10 50.19%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 47.45%


